These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9625435)

  • 21. Apoptosis induced by oxysterol in CEM cells is associated with negative regulation of c-myc.
    Ayala-Torres S; Zhou F; Thompson EB
    Exp Cell Res; 1999 Jan; 246(1):193-202. PubMed ID: 9882528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
    Per SR; Mattern MR; Mirabelli CK; Drake FH; Johnson RK; Crooke ST
    Mol Pharmacol; 1987 Jul; 32(1):17-25. PubMed ID: 3037302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
    Matsumoto Y; Takano H; Nagao S; Fojo T
    Jpn J Cancer Res; 2001 Sep; 92(9):968-74. PubMed ID: 11572765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.
    Yang CZ; Luan FJ; Xiong DS; Liu BR; Xu YF; Gu KS
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):333-7. PubMed ID: 7668104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase II inhibitor, VM-26.
    Orr MS; Fornari FA; Randolph JK; Gewirtz DA
    Biochim Biophys Acta; 1995 Jun; 1262(2-3):139-45. PubMed ID: 7599188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.
    Pommier Y; Orr A; Kohn KW; Riou JF
    Cancer Res; 1992 Jun; 52(11):3125-30. PubMed ID: 1317259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines.
    Snow K; Judd W
    Br J Cancer; 1991 Jan; 63(1):17-28. PubMed ID: 1989661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased CP-1 (NF-Y) activity results in transcriptional down-regulation of topoisomerase IIalpha in a doxorubicin-resistant variant of human multiple myeloma RPMI 8226.
    Wang H; Jiang Zg; Wong YW; Dalton WS; Futscher BW; Chan VT
    Biochem Biophys Res Commun; 1997 Aug; 237(2):217-24. PubMed ID: 9268689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
    Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH
    Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition by 1,25 dihydroxyvitamin D3 of c-myc down-regulation and DNA fragmentation in cytosine arabinoside-induced erythroid differentiation of K562 cells.
    Moore DC; Carter DL; Studzinski GP
    J Cell Physiol; 1992 Jun; 151(3):539-48. PubMed ID: 1295901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth arrest and non-apoptotic cell death associated with the suppression of c-myc expression in MCF-7 breast tumor cells following acute exposure to doxorubicin.
    Fornari FA; Jarvis DW; Grant S; Orr MS; Randolph JK; White FK; Gewirtz DA
    Biochem Pharmacol; 1996 Apr; 51(7):931-40. PubMed ID: 8651943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of the topoisomerase II induced DNA cleavage sites in the c-myc protooncogene by antitumor drugs is associated with gene expression.
    Riou JF; Lefevre D; Riou G
    Biochemistry; 1989 Nov; 28(23):9104-10. PubMed ID: 2557917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.
    Multon E; Riou JF; LeFevre D; Ahomadegbe JC; Riou G
    Biochem Pharmacol; 1989 Jul; 38(13):2077-86. PubMed ID: 2544183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
    Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cloning and expression of the Candida albicans TOP2 gene allows study of fungal DNA topoisomerase II inhibitors in yeast.
    Keller BA; Patel S; Fisher LM
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):329-39. PubMed ID: 9164874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity studies of amsacrine analogs in drug resistant human leukemia cell lines expressing either altered DNA topoisomerase II or P-glycoprotein.
    Granzen B; Graves DE; Baguley BC; Danks MK; Beck WT
    Oncol Res; 1992; 4(11-12):489-96. PubMed ID: 1363724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
    Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK
    Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrine.
    Baguley BC; Leteurtre F; Riou JF; Finlay GJ; Pommier Y
    Eur J Cancer; 1997 Feb; 33(2):272-9. PubMed ID: 9135499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered gene expression in human leukemia K562 cells selected for resistance to etoposide.
    Ritke MK; Yalowich JC
    Biochem Pharmacol; 1993 Dec; 46(11):2007-20. PubMed ID: 8267650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
    Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.